APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells

Chemoresistance is one of the leading causes of cancer-related deaths in the United States. Triple negative breast cancer (TNBC), a subtype lacking the known breast cancer receptors used for targeted therapy, is reliant on chemotherapy as the standard of care. The Adenomatous Polyposis Coli (APC) tu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neoplasia
Egile Nagusiak: Stefanski, Casey D., Keffler, Kaitlyn, McClintock, Stephanie, Milac, Lauren, Prosperi, Jenifer R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2019
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6872841/
https://ncbi.nlm.nih.gov/pubmed/31759252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.09.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak